Human ST2/IL-33 R Quantikine ELISA Kit
| Name | Human ST2/IL-33 R Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DST200 |
| Category | ELISA Kit |
| Prices | $519.00 |
| Sizes | 1 kit |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (50 uL), Serum (10 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL) |
| Sensitivity | 13.5 pg/mL |
| Range | 31.3 - 2,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human ST2/IL-33 R Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human ST2 in cell culture supernates, serum, and plasma |
| Gene | IL1RL1 |
| Supplier Page | Shop |
Product images
Product References
The injured heart: early cardiac effects of hematopoietic stem cell - The injured heart: early cardiac effects of hematopoietic stem cell
Rotz SJ, Ryan TD, Jodele S, Jefferies JL, Lane A, Pate A, Hirsch R, Hlavaty J, Levesque AE, Taylor MD, Cash M, Myers KC, El-Bietar JA, Davies SM, Dandoy CE. Bone Marrow Transplant. 2017 Aug;52(8):1171-1179.
Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated - Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated
Wojciechowska C, Romuk E, Nowalany-Kozielska E, Jachec W. Hellenic J Cardiol. 2017 Mar 28. pii: S1109-9666(16)30249-4. doi:
IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline. - IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline.
Fu AK, Hung KW, Yuen MY, Zhou X, Mak DS, Chan IC, Cheung TH, Zhang B, Fu WY, Liew FY, Ip NY. Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2705-13. doi:
Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. - Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment.
Yang J, Savvatis K, Kang JS, Fan P, Zhong H, Schwartz K, Barry V, Mikels-Vigdal A, Karpinski S, Kornyeyev D, Adamkewicz J, Feng X, Zhou Q, Shang C, Kumar P, Phan D, Kasner M, Lopez B, Diez J, Wright KC, Kovacs RL, Chen PS, Quertermous T, Smith V, Yao L, Tschope C, Chang CP. Nat Commun. 2016 Dec 14;7:13710.
Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the - Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the
Shen J, Shang Q, Wong CK, Li EK, Kun EW, Cheng IT, Li M, Li TK, Zhu TY, Yu CM, Qin L, Tam LS. Sci Rep. 2016 Aug 24;6:32116.
Phenotypic and genotypic association of epithelial IL1RL1 to human TH2-like - Phenotypic and genotypic association of epithelial IL1RL1 to human TH2-like
Traister RS, Uvalle CE, Hawkins GA, Meyers DA, Bleecker ER, Wenzel SE. J Allergy Clin Immunol. 2015 Jan;135(1):92-9.
Reduced IL-33 plasma levels in aplastic anemia. - Reduced IL-33 plasma levels in aplastic anemia.
Sun M, Ma HF, Che YY, Cui X. Cancer Cell Int. 2015 Dec 16;15:118.
IL1RL1 gene variants and nasopharyngeal IL1RL-a levels are associated with severe - IL1RL1 gene variants and nasopharyngeal IL1RL-a levels are associated with severe
Faber TE, Schuurhof A, Vonk A, Koppelman GH, Hennus MP, Kimpen JL, Janssen R, Bont LJ. PLoS One. 2012;7(5):e34364.
High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV - High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV
Miyagaki T, Sugaya M, Yokobayashi H, Kato T, Ohmatsu H, Fujita H, Saeki H, Kikuchi Y, Tamaki T, Sato S. J Invest Dermatol. 2011 Mar;131(3):794-6.
IL-33 mediates inflammatory responses in human lung tissue cells. - IL-33 mediates inflammatory responses in human lung tissue cells.
Yagami A, Orihara K, Morita H, Futamura K, Hashimoto N, Matsumoto K, Saito H, Matsuda A. J Immunol. 2010 Nov 15;185(10):5743-50.